The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China
AIM: To explore the process of retinal vascularization and risk factors for retinopathy of prematurity (ROP) treated with intravitreal ranibizumab (IVR) as monotherapy. METHODS: Infants with type 1 ROP who received IVR as primary treatment from August 2014 to October 2016 at Peking University Peopl...
Main Authors: | Qing-Yu Meng, Yong Cheng, Ming-Wei Zhao, Jian-Hong Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2019-07-01
|
Series: | International Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.cn/en_publish/2019/7/20190715.pdf |
Similar Items
-
Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
by: Lin CJ, et al.
Published: (2016-07-01) -
Evaluating peripheral retinal vascularization and rate of recurrence after intravitreal injection of ranibizumab as a primary treatment for retinopathy of prematurity
by: Mostafa M El Manhaly, et al.
Published: (2020-01-01) -
Retinal immaturity at first screening and retinopathy of prematurity: Image-based validation of 1202 eyes of premature infants to predict disease progression
by: Chaitra Jayadev, et al.
Published: (2019-01-01) -
Fluorescein angiography of retinal vascular involution after intravitreal injection of ranibizumab for retinopathy of prematurity
by: Yong Cheng, et al.
Published: (2019-01-01) -
The vascularization process after intravitreal ranibizumab injections for aggressive posterior retinopathy of prematurity
by: Emine Alyamaç Sukgen, et al.